Cargando…

Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study

OBJECTIVES: To assess the performance of statistical methods used to compare the effectiveness between drugs in an observational setting in the presence of attrition. METHODS: In this simulation study, we compared the estimations of low disease activity (LDA) at 1 year produced by complete case anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Mongin, Denis, Lauper, Kim, Finckh, Axel, Frisell, Thomas, Courvoisier, Delphine Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995805/
https://www.ncbi.nlm.nih.gov/pubmed/35027398
http://dx.doi.org/10.1136/annrheumdis-2021-221477
_version_ 1784684361610690560
author Mongin, Denis
Lauper, Kim
Finckh, Axel
Frisell, Thomas
Courvoisier, Delphine Sophie
author_facet Mongin, Denis
Lauper, Kim
Finckh, Axel
Frisell, Thomas
Courvoisier, Delphine Sophie
author_sort Mongin, Denis
collection PubMed
description OBJECTIVES: To assess the performance of statistical methods used to compare the effectiveness between drugs in an observational setting in the presence of attrition. METHODS: In this simulation study, we compared the estimations of low disease activity (LDA) at 1 year produced by complete case analysis (CC), last observation carried forward (LOCF), LUNDEX, non-responder imputation (NRI), inverse probability weighting (IPW) and multiple imputations of the outcome. All methods were adjusted for confounders. The reasons to stop the treatments were included in the multiple imputation method (confounder-adjusted response rate with attrition correction, CARRAC) and were either included (IPW2) or not (IPW1) in the IPW method. A realistic simulation data set was generated from a real-world data collection. The amount of missing data caused by attrition and its dependence on the ‘true’ value of the data missing were varied to assess the robustness of each method to these changes. RESULTS: LUNDEX and NRI strongly underestimated the absolute LDA difference between two treatments, and their estimates were highly sensitive to the amount of attrition. IPW1 and CC overestimated the absolute LDA difference between the two treatments and the overestimation increased with increasing attrition or when missingness depended on disease activity at 1 year. IPW2 and CARRAC produced unbiased estimations, but IPW2 had a greater sensitivity to the missing pattern of data and the amount of attrition than CARRAC. CONCLUSIONS: Only multiple imputation and IPW2, which considered both confounding and treatment cessation reasons, produced accurate comparative effectiveness estimates.
format Online
Article
Text
id pubmed-8995805
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-89958052022-04-27 Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study Mongin, Denis Lauper, Kim Finckh, Axel Frisell, Thomas Courvoisier, Delphine Sophie Ann Rheum Dis Epidemiology OBJECTIVES: To assess the performance of statistical methods used to compare the effectiveness between drugs in an observational setting in the presence of attrition. METHODS: In this simulation study, we compared the estimations of low disease activity (LDA) at 1 year produced by complete case analysis (CC), last observation carried forward (LOCF), LUNDEX, non-responder imputation (NRI), inverse probability weighting (IPW) and multiple imputations of the outcome. All methods were adjusted for confounders. The reasons to stop the treatments were included in the multiple imputation method (confounder-adjusted response rate with attrition correction, CARRAC) and were either included (IPW2) or not (IPW1) in the IPW method. A realistic simulation data set was generated from a real-world data collection. The amount of missing data caused by attrition and its dependence on the ‘true’ value of the data missing were varied to assess the robustness of each method to these changes. RESULTS: LUNDEX and NRI strongly underestimated the absolute LDA difference between two treatments, and their estimates were highly sensitive to the amount of attrition. IPW1 and CC overestimated the absolute LDA difference between the two treatments and the overestimation increased with increasing attrition or when missingness depended on disease activity at 1 year. IPW2 and CARRAC produced unbiased estimations, but IPW2 had a greater sensitivity to the missing pattern of data and the amount of attrition than CARRAC. CONCLUSIONS: Only multiple imputation and IPW2, which considered both confounding and treatment cessation reasons, produced accurate comparative effectiveness estimates. BMJ Publishing Group 2022-05 2022-01-13 /pmc/articles/PMC8995805/ /pubmed/35027398 http://dx.doi.org/10.1136/annrheumdis-2021-221477 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology
Mongin, Denis
Lauper, Kim
Finckh, Axel
Frisell, Thomas
Courvoisier, Delphine Sophie
Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study
title Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study
title_full Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study
title_fullStr Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study
title_full_unstemmed Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study
title_short Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study
title_sort accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995805/
https://www.ncbi.nlm.nih.gov/pubmed/35027398
http://dx.doi.org/10.1136/annrheumdis-2021-221477
work_keys_str_mv AT mongindenis accountingformissingdatacausedbydrugcessationinobservationalcomparativeeffectivenessresearchasimulationstudy
AT lauperkim accountingformissingdatacausedbydrugcessationinobservationalcomparativeeffectivenessresearchasimulationstudy
AT finckhaxel accountingformissingdatacausedbydrugcessationinobservationalcomparativeeffectivenessresearchasimulationstudy
AT frisellthomas accountingformissingdatacausedbydrugcessationinobservationalcomparativeeffectivenessresearchasimulationstudy
AT courvoisierdelphinesophie accountingformissingdatacausedbydrugcessationinobservationalcomparativeeffectivenessresearchasimulationstudy